type 2 diabetes
Conditions
Interventions
10 inpatients who are treated with insulin for type 2 diabetes or 5 inpatients without diabetes. All patients will drink water (1st day), OS-1 (2nd day) and Arginaid Water (3rd day).
Sponsors
Department of Metabolic Medicine, Kumamoto University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inpatients treated with insulin for type 2 diabetes whom glycemic control are stable (fasted blood glucose level is less than 150 mg/dL, and postpradial blood glucose level is less than 250 mg/dL).
Exclusion criteria
Exclusion criteria: Type 1 diabetes Patients treated with steroid Patients whom fasted blood glucose level is more than 150 mg/dL Patients whom postpradial blood glucose level is more than 250 mg/dL Patients who have severe autonomic failure Patients who were admitted with diabetic ketoacidosis, hyperosmolar hyperglycemic nonketotic coma or lactic acidosis Patients treated with continuous injection Patients who have appetite loss or are unable to eat orally
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is blood glucose level. Especially, it will compare the fluctuation of blood glucose level loading oral carbohydrate beverage with its loading water. | — |
Countries
Japan
Contacts
Public ContactJunji Kawashima
Faculty of Life Sciences, Kumamoto University Department of Metabolic Medicine
Outcome results
None listed